These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24511105)

  • 1. Differential impact of hepatic deficiency and total body inhibition of MTP on cholesterol metabolism and RCT in mice.
    Dikkers A; Annema W; de Boer JF; Iqbal J; Hussain MM; Tietge UJ
    J Lipid Res; 2014 May; 55(5):816-25. PubMed ID: 24511105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs.
    Iqbal J; Boutjdir M; Rudel LL; Hussain MM
    J Lipid Res; 2014 Nov; 55(11):2261-75. PubMed ID: 25030663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
    Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
    J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein.
    Xie Y; Kennedy S; Sidhu R; Luo J; Ory DS; Davidson NO
    Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1624-31. PubMed ID: 22580900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin-mediated differential regulation of microsomal triglyceride transfer protein in the intestine and liver affects plasma lipids.
    Iqbal J; Mascareno E; Chua S; Hussain MM
    J Biol Chem; 2020 Mar; 295(13):4101-4113. PubMed ID: 32047110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.
    Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid absorption defects in intestine-specific microsomal triglyceride transfer protein and ATP-binding cassette transporter A1-deficient mice.
    Iqbal J; Parks JS; Hussain MM
    J Biol Chem; 2013 Oct; 288(42):30432-30444. PubMed ID: 24019513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.
    Wang Y; Liu X; Pijut SS; Li J; Horn J; Bradford EM; Leggas M; Barrett TA; Graf GA
    J Lipid Res; 2015 Apr; 56(4):810-20. PubMed ID: 25635125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary sterol secretion is required for functional in vivo reverse cholesterol transport in mice.
    Nijstad N; Gautier T; Briand F; Rader DJ; Tietge UJ
    Gastroenterology; 2011 Mar; 140(3):1043-51. PubMed ID: 21134376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides.
    Lin MC; Arbeeny C; Bergquist K; Kienzle B; Gordon DA; Wetterau JR
    J Biol Chem; 1994 Nov; 269(46):29138-45. PubMed ID: 7961879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A deficiency of microsomal triglyceride transfer protein reduces apolipoprotein B secretion.
    Leung GK; Véniant MM; Kim SK; Zlot CH; Raabe M; Björkegren J; Neese RA; Hellerstein MK; Young SG
    J Biol Chem; 2000 Mar; 275(11):7515-20. PubMed ID: 10713055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
    Dikkers A; de Boer JF; Groen AK; Tietge UJ
    Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.
    Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ
    Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis.
    Spann NJ; Kang S; Li AC; Chen AZ; Newberry EP; Davidson NO; Hui ST; Davis RA
    J Biol Chem; 2006 Nov; 281(44):33066-77. PubMed ID: 16950764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intrinsic gut leptin-melanocortin pathway modulates intestinal microsomal triglyceride transfer protein and lipid absorption.
    Iqbal J; Li X; Chang BH; Chan L; Schwartz GJ; Chua SC; Hussain MM
    J Lipid Res; 2010 Jul; 51(7):1929-42. PubMed ID: 20164094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic SR-BI, not endothelial lipase, expression determines biliary cholesterol secretion in mice.
    Wiersma H; Gatti A; Nijstad N; Kuipers F; Tietge UJ
    J Lipid Res; 2009 Aug; 50(8):1571-80. PubMed ID: 19252221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal triglyceride transfer protein enhances cellular cholesteryl esterification by relieving product inhibition.
    Iqbal J; Rudel LL; Hussain MM
    J Biol Chem; 2008 Jul; 283(29):19967-80. PubMed ID: 18502767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
    Phillips C; Bennett A; Anderton K; Owens D; Collins P; White D; Tomkin GH
    Metabolism; 2002 Jul; 51(7):847-52. PubMed ID: 12077729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss.
    Brown JM; Bell TA; Alger HM; Sawyer JK; Smith TL; Kelley K; Shah R; Wilson MD; Davis MA; Lee RG; Graham MJ; Crooke RM; Rudel LL
    J Biol Chem; 2008 Apr; 283(16):10522-34. PubMed ID: 18281279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice.
    He H; Wang J; Yannie PJ; Kakiyama G; Korzun WJ; Ghosh S
    J Biol Chem; 2018 Jun; 293(24):9223-9231. PubMed ID: 29700117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.